About 9 results found for searched term "Thromboxane B2" (0.127 seconds)
Cat.No. | Name | Target |
---|---|---|
M39793 | Thromboxane B2 | Others |
Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation. | ||
M42383 | 11-Dehydro-thromboxane B2 | Metabolite/Endogenous Metabolite |
11-Dehydro-thromboxane B2 is a platelet hemagglutinin. | ||
M3089 | Triflusal | COX |
Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1. | ||
M4444 | 2,3,5,4-tetrahydroxyl-diphenylethylene-2-o-glucoside | Others |
2,3,4',5-Tetrahydroxystilbene 2-O-D-glucoside | ||
2,3,4', 5-Tetrahydroxystilbene 2-O-D-glucoside was isolated from the roots of polygonum species and inhibited the formation of 5-Hete, HHT and Thromboxane B2. | ||
M7095 | Ozagrel hydrochloride | Others |
Ozagrel hydrochloride is a selective thromboxane A 2 synthetase inhibitor. | ||
M7769 | Daltroban | Others |
Selective thromboxane A2 receptor antagonist. | ||
M18309 | p-Hydroxy-cinnamic acid | Metabolite/Endogenous Metabolite |
p-Hydroxy-cinnamic acid inhibits platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively. | ||
M29143 | NTP42 | Prostaglandin Receptor |
NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM for antagonizing T prostanoid receptor (TP)- mediated [Ca2+] mobilization following stimulation of cells with the alternative TP agonist U46619. NTP42 can be used for the treatment of pulmonary arterial hypertension (PAH). | ||
M30263 | NP-313 | Thrombopoietin/Thrombin |
NP-313 is a potent antithrombotic agent that inhibits platelet aggregation and activation. NP-313 has dual inhibition of thromboxane A 2 synthesis and selective inhibition of SOCC-mediated Ca2+ inward flow. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.